Dopamine Agents [clinicaltrials_resource:bdbc4c305fbda595a8ec3172871bbfdf]
Embryonic Dopamine Cell Implants for Parkinson's Disease [clinicaltrials:NCT00038116]Role of Dopamine in Response to Alcohol [clinicaltrials:NCT00050219]PET Imaging of Dopamine in Healthy Study Participants [clinicaltrials:NCT00062946]Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112 [clinicaltrials:NCT00088517]Relationship of Dopamine to Cognitive Function in Parkinson's Disease [clinicaltrials:NCT00094601]clinicaltrials:NCT00102869Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia [clinicaltrials:NCT00111371]Donor Dopamine and Initial Graft Function [clinicaltrials:NCT00115115]Dopamine Receptor Imaging in Mood Disorders [clinicaltrials:NCT00116077]Potentiation of Procedural Motor Learning in Health and Disease [clinicaltrials:NCT00126087]clinicaltrials:NCT00153972Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects [clinicaltrials:NCT00166322]Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists [clinicaltrials:NCT00196898]Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions [clinicaltrials:NCT00280501]Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment [clinicaltrials:NCT00306124]Dopamine and Norepinephrine in Shock Patients [clinicaltrials:NCT00314704]A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [clinicaltrials:NCT00335205]Quetiapine and the Dopaminergic Epigenetic Control [clinicaltrials:NCT00370500]A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers. [clinicaltrials:NCT00396669]OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine [clinicaltrials:NCT00401999]clinicaltrials:NCT00443872Impact of Switching to Continuous Release Dopamine Agonists [clinicaltrials:NCT00465452]Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors [clinicaltrials:NCT00471588]Brain Dopamine Function in Adults With ADHD [clinicaltrials:NCT00580814]clinicaltrials:NCT00592943clinicaltrials:NCT00604019MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist [clinicaltrials:NCT00605683]clinicaltrials:NCT00634556Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease [clinicaltrials:NCT00666653]Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa [clinicaltrials:NCT00670293]clinicaltrials:NCT00685919SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease [clinicaltrials:NCT00725478]Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD [clinicaltrials:NCT00756158]Dopamine and Insulin Resistance [clinicaltrials:NCT00802204]24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study [clinicaltrials:NCT00818298]Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia [clinicaltrials:NCT00825045]A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control [clinicaltrials:NCT00830739]clinicaltrials:NCT00874393Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies [clinicaltrials:NCT00917709]clinicaltrials:NCT00937092
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Dopamine Agents [clinicaltrials_resource:bdbc4c305fbda595a8ec3172871bbfdf]
Bio2RDF identifier
bdbc4c305fbda595a8ec3172871bbfdf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bdbc4c305fbda595a8ec3172871bbfdf
identifier
clinicaltrials_resource:bdbc4c305fbda595a8ec3172871bbfdf
title
Dopamine Agents
@en
type
label
Dopamine Agents [clinicaltrials_resource:bdbc4c305fbda595a8ec3172871bbfdf]
@en